For the Inventor, By the Inventor

Enter assignee name

San Diego, CA, United States of America

Vaxiion Therapeutics, LLC

USPTO Granted Patents = 22

% Expired Patents = 27.3

EPO Patents = 6

Forward Citations = 236

Loading Chart...

Loading Chart...

9 inventors (with patents filed for the assignee):

Matthew J Giacalone (15 out of 15 patents)

Mark William Surber (8 out of 37 patents)

Neil Berkley (8 out of 9 patents)

4. Roger A Sabbadini (8 out of 36 patents)

5. Robert Klepper (3 out of 5 patents)

6. Gary H Ward (3 out of 10 patents)

7. Stanley Maloy (2 out of 2 patents)

8. Shingo Tsuji (2 out of 2 patents)

9. Michael James Newman (2 out of 10 patents)

22 patents: Sort by Forward Citations

1. 12741010 - Immunomodulatory and oncolytic minicells and methods of use (2026-09-22),

2. 12427172 - Ionizing irradiation sterilization of bacterial minicell-based biopharmaceuticals and methods of use (2025-09-30),

3. 11564953 - Ionizing irradiation sterilization of bacterial minicell-based biopharmaceuticals and methods of use (2023-01-31),

4. 11219679 - Immunomodulatory minicells and methods of use (2022-01-11),

5. 11167008 - Immunomodulatory and oncolytic minicells and methods of use (2021-11-09),

6. 10919942 - Therapeutic compositions and methods for antibody and Fc-containing targeting molecule-based targeted delivery of bioactive molecules by bacterial minicells (2021-02-16),

7. 10561719 - Immunomodulatory minicells and methods of use (2020-02-18),

8. 10124024 - Ionizing irradiation sterilization of bacterial minicell-based biopharmaceuticals and methods of use (2018-11-13),

9. 10039817 - Immunomodulatory minicells and methods of use (2018-08-07),

10. 10005820 - Therapeutic compositions and methods for antibody and Fc-containing targeting molecule-based targeted delivery of bioactive molecules by bacterial minicells (2018-06-26),

11. 9670270 - Minicell based delivery of biologically active compounds (2017-06-06),

12. 9574196 - Regulated genetic suicide mechanism compositions and methods (2017-02-21),

13. 9566321 - Immunomodulatory minicells and methods of use (2017-02-14),

14. 9267108 - Immunomodulatory minicells and methods of use (2016-02-23),

15. 9045761 - Regulated genetic suicide mechanism compositions and methods (2015-06-02),

Company Overview

Vaxiion Therapeutics, LLC is a biotechnology company based in San Diego, California, specializing in the development of innovative therapies for cancer treatment. The company focuses on harnessing the power of the immune system to create targeted therapies that enhance the body's natural ability to fight tumors. Vaxiion's research emphasizes the use of advanced technologies in immunotherapy, aiming to improve patient outcomes through precision medicine and novel treatment modalities.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

22 Patents

#274 in San Diego, CA

#3,590 in California

#15,051 in US

#28,807 in the World

San Diego, CA, United States of America

Vaxiion Therapeutics, LLC

Forward Citations = 236

9 inventors:

Matthew J Giacalone (15 out of 15 patents)

Mark William Surber (8 out of 37 patents)

Neil Berkley (8 out of 9 patents)

4. Roger A Sabbadini (8 out of 36 patents)

5. Robert Klepper (3 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Vaxiion Therapeutics, LLC. Retrieved from https://idiyas.com/company/vaxiion-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…